Transdermal Medical Patch Market in North America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Transdermal Medical Patch Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Transdermal Medical Patch Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Growing Consumption of Tobacco

5.2 Market Opportunities

5.2.1 Increasing Strategic Initiatives

5.3 Future Trends

5.3.1 Advancements in Smart Patches and Three- Dimensional (3D)-Printed Patches

5.4 Impact of Drivers and Restraints

6. North America Transdermal Medical Patch Market Regional Analysis

6.1 North America Transdermal Medical Patch Market Overview

6.2 North America Transdermal Medical Patch Market Revenue 2021-2028 (US$ Million)

6.3 North America Transdermal Medical Patch Market Forecast Analysis

7. North America Transdermal Medical Patch Market Analysis – by Type

7.1 Single Layer Drug-in-Adhesive

7.1.1 Overview
7.1.2 Single Layer Drug-in-Adhesive: North America Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Multi-layer Drug-in-Adhesive

7.2.1 Overview
7.2.2 Multi-layer Drug-in-Adhesive: North America Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Reservoir

7.3.1 Overview
7.3.2 Reservoir: North America Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Vapor Patch

7.4.1 Overview
7.4.2 Vapor Patch: North America Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Matrix

7.5.1 Overview
7.5.2 Matrix: North America Transdermal Medical Patch Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Transdermal Medical Patch Market Analysis – by Application

8.1 Neurologic Conditions

8.1.1 Overview
8.1.2 Neurologic Conditions: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Pain Management

8.2.1 Overview
8.2.2 Pain Management: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Nicotine Cessation

8.3.1 Overview
8.3.2 Nicotine Cessation: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Cardiovascular Disorders

8.4.1 Overview
8.4.2 Cardiovascular Disorders: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hormonal Therapy

8.5.1 Overview
8.5.2 Hormonal Therapy: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Transdermal Medical Patch Market Analysis – by Distribution Channel

9.1 Hospital Pharmacies

9.1.1 Overview
9.1.2 Hormonal Therapy: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Retail Pharmacies

9.2.1 Overview
9.2.2 Hormonal Therapy: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Online Pharmacies

9.3.1 Overview
9.3.2 Hormonal Therapy: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Transdermal Medical Patch Market – North America Analysis

10.1 North America

10.1.1 North America Transdermal Medical Patch Market Breakdown, by Key Country, 2024 and 2028 (%)
10.1.1.1 North America Transdermal Medical Patch Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America Transdermal Medical Patch Market Breakdown, by Type
10.1.1.1.2 US: North America Transdermal Medical Patch Market Breakdown, by Application
10.1.1.1.3 US: North America Transdermal Medical Patch Market Breakdown, by Distribution Channel

10.1.1.2 Canada: North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America Transdermal Medical Patch Market Breakdown, by Type
10.1.1.2.2 Canada: North America Transdermal Medical Patch Market Breakdown, by Application
10.1.1.2.3 Canada: North America Transdermal Medical Patch Market Breakdown, by Distribution Channel

10.1.1.3 Mexico : North America Transdermal Medical Patch Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America Transdermal Medical Patch Market Breakdown, by Type
10.1.1.3.2 Mexico : North America Transdermal Medical Patch Market Breakdown, by Application
10.1.1.3.3 Mexico : North America Transdermal Medical Patch Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Transdermal Medical Patch Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Hisamitsu Pharmaceutical Co Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Medline Industries LP

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Johnsons and Johnsons

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Novartis AG

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Teva Pharmaceutical Industries Ltd.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 UCB SA

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Viatris Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Endo International Inc

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Boehringer Ingelheim International GmbH

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Corium, LLC

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights